Ángel Sánchez Recalde

Effectiveness and safety beyond 10 years of percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.

F. Gimeno de Carlos, J. Zueco Gil, M. Sabaté Tenas, 2014, Revista espanola de cardiologia.

Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry).

M. Masotti, F. Alfonso, R. Calviño, 2013, The American journal of cardiology.